Bioinvent International AB

Bioinvent International AB

2 lediga jobb

Om Bioinvent International AB

About BioInvent

BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently three drug candidates in four ongoing clinical programs in Phase 1/2 trials for the treatment of hematological cancer and solid tumors, respectively. The Company’s validated, proprietary F.I.R.S.T™ technology platform simultaneously identifies both targets and the antibodies that bind to them, generating many promising new drug candidates to fuel the Company’s own clinical development pipeline or for additional licensing and partnering. The Company generates revenues from research collaborations and license agreements with multiple top-tier pharmaceutical companies, as well as from producing antibodies for third parties in the Company’s fully integrated manufacturing unit. More information is available at www.bioinvent.com. Follow us on Twitter: @BioInvent.

Storlek

100-199 anställda

Huvudkontor

Lund

Omsättning

73 Mkr (2023)

Grundades

1997

VD

Martin Welschof
Lund
Heltid
Forskare
9 dagar sedan
BioInvent International AB BioInvent International AB Lund
Heltid
Lund
Heltid
Forskare
9 dagar sedan